company

Obesity

Obesity poses a major public health challenge. Each year, obesity contributes to an estimated 112,000 preventable deaths.5 Obese adults are at increased risk for many serious health conditions, including high blood pressure, high cholesterol, type 2 diabetes and its complications, coronary heart disease, stroke, gallbladder disease, osteoarthritis, sleep apnea, and respiratory problems, as well as endometrial, breast, prostate, and colon cancers.6 Children with a high body mass index (BMI), an indicator of excess body weight, are more likely than those with a normal BMI to have insulin resistance7 (which can lead to diabetes), high blood pressure, and unhealthy levels of fats and other lipids. Furthermore, obese children often become obese adults; some studies have found that even 2- to 5-year-olds with a high BMI are likely to become obese adults.8 Besides suffering from physical illnesses, obese adults and children also may experience social stigmatization and discrimination, as well as psychological problems.

Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize treatment of chronic disease. As a company, we believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives.

The Obalon balloon gives you a non-surgical, fully reversible, weight loss option... read more

EnteroMedics Inc. (NASDAQ: ETRM) has developed VBLOCÆ vagal blocking therapy, a unique, broadly patented therapeutic approach designed to treat a range of gastrointestinal and metabolic diseases. VBLOC Therapy is a first-in-class weight loss treatment designed to help address the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension.

VBLOC Therapy, delivered by a pacemaker-like device called the MaestroÆ Rechargeable System, is designed to control both hunger and fullness by blocking the primary nerve which regulates the digestive system. VBLOC Therapy is designed to address the lifelong challenge of obesity by empowering people to take a positive path toward weight loss without compromising their lifestyle... read more

Bariatec Corporation is a medical device company that designs and manufactures products for use in the bariatric (“obesity”) surgery markets. It was founded in 2007 by the world-renowned bariatric surgeon, Dr. Mathias Fobi, M.D., inventor of the “Fobi Pouch” operation. Bariatec Corporation is currently producing one device, the patented and proprietary GaBP Ring Autolock™ System, for use in Gastric Bypass and Sleeve Gastrectomy operations worldwide.

The GaBP Ring Autolock™ System is designed to improve the effectiveness of the bariatric surgeries by increasing weight loss and enhancing weight loss maintenance. The device has a worldwide patent, CE Mark approval for sale in Europe, and is the only device of its kind having entered and completed FDA trials for distribution in the United States... read more